ARE-LABS · PLATFORM · 2026ARE Labs

ARE Labs

Elevating Innovation
One Aerosol at a Time.

Independent aerosol science for bioaerosol, pharmaceutical, inhalation, emissions, surface, and package integrity studies. Precision instrumentation meets regulatory rigor.

PARTICLE VORTEX ONLINE
We test

Drug delivery devices, air cleaners, respirators, packaging, antimicrobial surfaces, and air-interacting products.

We measure

Particle size, aerosol dose, microbial reduction, emissions, package integrity, and inhalation performance.

We report

Protocols, controls, figures, datasets, and interpretation limits in a reviewable evidence package.

Proof scale
900+

Studies performed across aerosol, bioaerosol, and inhalation programs.

ARE Labs turns product claims, technical questions, and regulatory evidence needs into controlled laboratory studies and defensible reports.

17+
Years in operation
17025
Quality-oriented records
BSL-2
Bioaerosol capable
Ready to scope

Bring us the aerosol question. Leave with a study plan.

Send the device, formulation, claim, or regulatory frame. ARE Labs will return a scoped method plan with the controls, deliverables, and timeline needed to move.

What ARE Labs does

Independent testing for products that move through air.

ARE Labs measures aerosol behavior, microbial challenge, inhalation performance, emissions, surface efficacy, and package integrity, then turns the results into clear reports.

Pharmaceutical aerosol

Dose, particle size, and inhalation performance translated into defensible data.

ARE Labs builds method plans around the formulation, device, flow path, and decision. Outputs can include particle size, emitted dose, delivered dose, comparability, and limits of interpretation.

Open evidence path
01MDI / DPI / nebulizer / nasal spray
cascade impactorstage cut / dose mass
S0>10 um
S15.8 um
S23.2 um
S31.8 um
S40.9 um
MMAD3.2 umcascade fit
FPF62%fine-particle fraction
Dose96%emitted dose recovery
Bioaerosol and air-device claims

Challenge studies for air devices, filters, and antimicrobial claims.

For air treatment, antimicrobial, filtration, and room-device programs, ARE Labs controls organisms, aerosol generation, sampling, timing, recovery, and reporting so claims are tested against defined conditions.

Open evidence path
02Room device / filter / disinfection / reduction
microbial constellation map
challenge cloud
control group
recovery signal

Challenge conditions, controls, recovery, reduction data

High-tech measurement stack

Measurement strategy selected around the question.

No single readout answers every aerosol question. ARE Labs combines particle physics, analytical chemistry, device handling, environmental controls, and standards mapping into a fit-for-purpose study.

Open evidence path
03APS / FMPS / Spraytec / GC / CCI
Particle size distributionPSD / dose profile
D101.2 umD504.6 umD908.8 um
PSDDv50 4.6 umlognormal fit / span 1.8
Dose97% emitteddelivered-dose window
Run fitRSD 3.2%replicate overlay
Device testing

Device and product testing ARE Labs can support.

Start from the product category when the evidence need is commercial, regulated, or claim-critical. These device paths route into aerosol, bioaerosol, inhalation, surface, and package integrity methods.

Study flow

Custom study design, made visible.

Method choice, controls, standards alignment, and deliverables are defined around the decision the data has to support.

01

Define the decision

We identify the claim, change, exposure question, or submission need the data must support.

02

Select the method

Instruments, challenge conditions, flows, replicates, controls, and standards alignment are set before the run.

03

Run the study

Samples move through controlled aerosol, bioaerosol, analytical, or environmental workflows with records attached.

04

Report the evidence

Reports include methods, controls, figures, raw datasets, and clear limits of interpretation.